hotspot -WSS

hotspot

author：comprehensive 2025-10-02 18:46:34 - browse：9

SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to the previous year.

The market’s response was swift. Minutes after the company issued its press release, shares in Illumina dipped from $184.49 to below $172 during after-hours trading.

In its release, Illumina noted that it expects revenue from the company’s core business to be essentially the same this year compared to last, and that it expects revenue from Grail, the cancer diagnostics company that Illumina acquired for $8 billion in the fall of 2021, to remain in the range of $90 and $100 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Medical devices makers are asking for forgiveness, not permission

leisure time

WSS

'Patient friction coefficient' can gauge a clinical trial's patient burden

Timeline: Special counsel's probe into Trump's handling of classified documents

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Hospitals, health systems can help patients avoid medical debt

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Wikipedia

hotspot

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bring on the sabbaticals for nurses

Novavax promises a turnaround & Lilly roils the obesity market

'The boss' wants server deleted: New allegations emerge in Trump indictment

As demand for Covid shots wanes, Moderna seeks its next success

Medicare Advantage insurers pressure Biden for bigger payments

Sports medicine is finally prioritizing gender equality

The mammogram wars are not over

explore

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Testing GLP

Will biotech layoffs continue through 2023?

Medical devices makers are asking for forgiveness, not permission

Timeline: Special counsel's probe into Trump's handling of classified documents

focus

leisure time

explore

entertainment